AI Agents for Clinical Trial Matching

A practical reference showing how AI agents perform clinical trial matching, from goal to action, with a concrete worked example and required tooling, data, and governance.

By Suhas Bhairav · Updated

Direct Answer

AI agents for clinical trial matching are goal-driven software that identify suitable trials for patients, plan steps, call data tools, verify results, and stop or hand off. They pursue enrollment eligibility, matching accuracy, data integrity, audit trails, and clear human checks to maintain safety and compliance.

Best for: Clinical operations leads and data engineering teams.

What AI Agents Can Do in Clinical Trial Matching

  • Goal setting

    Define the objective: select patient cohorts, list candidate trials, and determine required data fields. Plan milestones, resource use, and decision points; proceed until results meet thresholds or a human review is triggered.

  • Trial cohorting

    Identify candidate trials by indications, phases, and sites; pull inclusion/exclusion criteria; build a candidate list, rank by relevance, and flag conflicts or missing data for follow-up.

  • Data gathering

    Query EHRs and trial databases, extract demographics, diagnoses, lab results, and consent status; validate data quality, standardize formats, and surface data gaps needing manual verification.

  • Eligibility checking

    Apply criteria checks across records; compute eligibility flags, note exceptions, and document reasons for rejection or requirement for clinician review.

  • Consent and logistics

    Assess consent status, contact sites, and schedule assessments; generate outreach actions, update trackers, and log decisions for audit purposes.

  • Audit and handoff

    Record decision rationale, preserve data lineage, and escalate uncertain cases to a clinician or trial coordinator with a complete context.

How the Agent Works

  1. Receive the goal

    The agent receives the patient profile, trial goal, criteria, and data access; it initializes planning around data needs and decision thresholds.

  2. Plan

    The agent creates a stepwise plan: data queries, candidate filters, eligibility checks, and a gating review before outreach.

  3. Call tools

    The agent queries EHRs, trial registries, and consent databases; it aggregates results, notes data quality, and flags gaps.

  4. Check result

    The agent validates results against criteria, computes eligibility, and attaches audit-ready justifications; decides whether to proceed or trigger clinician review.

  5. Finish or hand off

    If criteria are met and data are solid, the agent completes outreach; otherwise, it hands off to a clinician with full context.

Worked Example

Matching a patient to eligible trials and scheduling consent checks

Illustrative scenario with sample data.

Scenario

A mid-sized hospital network needs to enroll a patient with type 2 diabetes and renal impairment into a suitable Phase 2 trial. The trial team wants a reproducible, auditable matching flow that respects privacy and site constraints.

Input

patientId: P-2048; age: 58; sex: F; diagnosis: type 2 diabetes; eGFR: 40; prior trials: none; preferred sites: S1, S3; consent: pending; dataAccess: granted; regulatory: IRB approved.

What the agent does

  1. Tool: Trial Registry API; the agent retrieves all Phase 2 diabetes trials with renal criteria; it returns 12 candidates and notes site availability. It then filters for eGFR thresholds and consent status, reducing to 5 viable trials; it decides to proceed to data pull.
  2. Tool: EHR query; the agent pulls demographics, labs, and medications for the patient; it detects a conflicting medication that requires clinician review and flags it. It updates the candidate list and plans outreach sequencing.
  3. Tool: Eligibility checker; the agent applies inclusion/exclusion criteria; it marks 2 trials as eligible, 2 as ineligible due to lab values, and 1 as require clinician confirmation due to comorbidity complexity.
  4. Tool: Consent tracker; the agent prepares outreach messages to sites S1 and S3 and drafts a consent status update for the patient portal; it queues clinician review for the flagged drug interaction.

Output

Record shows: patient P-2048 matches Trial T-101 and T-208 with eligibility flags, site S1 pending consent, S3 awaiting site confirmation; data quality notes indicate complete demographics and renal function; next steps: clinician review of drug interaction and outreach to sites.

Human decision

A clinician must verify the drug interaction flag, approve outreach messages, and confirm that patient consent will be updated in the portal before any contact or next-step actions.

What You Need

  • Access to EHR, trial registries, and consent databases with read permissions
  • Structured patient data fields: demographics, diagnoses, labs, medications, consent status
  • Clear data governance: privacy rules, audit trails, and data retention policies
  • Logging: event timestamps, data sources, decision rationales, and reviewer notes

Where People Stay in Charge

  • The agent cannot authorize patient outreach without clinician sign-off on flagged interactions or sensitive data
  • The agent must hand off any ambiguous eligibility or consent questions to a qualified clinician for review
  • The agent should provide a complete audit trail and allow human override at all decision points

FAQ

What is clinical trial matching with AI agents?

Clinical trial matching with AI agents is a goal-driven process that gathers patient data, applies criteria, and orchestrates outreach. The agent plans actions, calls tools, checks results, and hands off at human review points.

What data sources does the agent use?

It uses electronic health records, trial registries, consent databases, and site calendars. It standardizes formats, checks data quality, and surfaces gaps for clinician verification.

When does the agent stop?

The agent stops when criteria are met and outreach is prepared or a clinician review is triggered. It logs decisions and preserves data lineage.

Who approves final trial enrollment?

A clinician or trial coordinator must approve final enrollment, especially when eligibility is uncertain, data quality is unclear, or consent requires confirmation.